Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial

David C. Smith*, Matthew R. Smith, Christopher Sweeney, Aymen A. Elfiky, Christopher Logothetis, Paul G. Corn, Nicholas J. Vogelzang, Eric J. Small, Andrea L. Harzstark, Michael S. Gordon, Ulka N. Vaishampayan, Naomi B. Haas, Alexander I. Spira, Primo N. Lara, Chia Chi Lin, Sandy Srinivas, Avishay Sella, Patrick Schöffski, Christian Scheffold, Aaron L. WeitzmanMaha Hussain

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

353 Scopus citations

Fingerprint

Dive into the research topics of 'Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial'. Together they form a unique fingerprint.

Medicine & Life Sciences